aid: arrepath
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrepath.png
name: ArrePath
description: 'ArrePath is an AI-driven pharmaceutical company based in Princeton, New Jersey, applying
  machine learning to accelerate small-molecule drug discovery in infectious disease. Its platform treats
  heterogeneous, small, and noisy bioactivity datasets as a modeling opportunity, enabling work on novel
  chemical classes where conventional approaches struggle; a public-data oral bioavailability model lifted
  a lead series from roughly 22% to 89% bioavailability. Lead programs include an oral LpxH inhibitor for
  outpatient urinary tract infections (pre-IND targeted mid-2026) and antibacterial programs against
  non-tuberculous mycobacterial (NTM) lung disease and tuberculosis, plus an early non-infectious discovery
  effort. ArrePath is a portfolio company of Insight Partners. It publishes no public developer API,
  documentation, or SDKs; this profile captures company identity and domain-security posture.'
url: https://raw.githubusercontent.com/api-evangelist/arrepath/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech Therapeutics
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Infectious Disease
- Antibacterials
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/arrepath-domain-security.yml
- type: Website
  url: https://arrepath.com/
- type: Blog
  url: https://arrepath.com/news
- type: Support
  url: https://arrepath.com/contact-us
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence